IF YOU’D LIVED in Grand Rapids, Michigan, in 1945, you’d have been one of the first people in America to sip fluoridated tap water. As of 2024, about 73 percent of us get the mineral in our water supply. And for almost 80 years, there’s been nonstop drama around that addition. In 1956, Clive McCay, …
WE’RE IN CRUNCH time on what just may be the final season of Yellowstone; the only episode left to air is season 5, episode 14, which just might be the series finale (though Paramount Network’s marketing has yet to refer to it as that). There are several storylines still open, several mysteries still to be …
Bella Hadid Made a Surprise Cameo on Yellowstone For Some Reason Read More »
For much of his life, 38-year-old Ben Johnson never stepped foot in a gym. He didn’t think twice about chugging cans of Mountain Dew everyday between Burger King drive-thrus. But in 2016, Johnson was feeling heavy and out of shape. So he decided to take control of his health. First, he focused on cutting processed …
How This Guy Went From Couch to Running 12 Marathons in 12 Months Read More »
Best Overall Gym Towel G Grounded Sport Fitness Towel Cons May be too large for some smaller individuals We chose Grounded Sport’s Fitness towel as our top pick because it performed the best in our tests, looks great, is well-made, and is available at a fair price. During our absorbability test, Grounded Sport’s Fitness towel …
The 6 Best Gym Towels, Tested by Editors and Trainers Read More »
Arc’teryx Sabre Jacket Our gear and style editors agree: Arc’teryx makes some of the toughest and best-looking ski jackets around. Take its new Sabre coat that comes in the brand’s Grottoflague print, a stylish take on the camo menswear trend. Plus, it performs as well as it looks, with a Gore-tex shell that does a …
MH Style Gains: The Best Menswear Releases This December Read More »
SAN DIEGO — Omitting 24-hour urine testing from multiple myeloma response assessments does not compromise accurate tracking of patients’ responses to treatment, a new analysis indicates. Overall, evaluating patients’ responses using urine-free and traditional criteria led to nearly identical assessments. When comparing the two criteria, only seven of 645 patients evaluated had discordant results. The …
24-Hour Urine Testing in Multiple Myeloma: Time to Stop? Read More »
SAN DIEGO — Phase 3 data support rilzabrutinib as a potential first-in-class oral Bruton tyrosine kinase (BTK) inhibitor for patients with previously treated immune thrombocytopenia (ITP). In the LUNA 3 trial, treatment with rilzabrutinib (Sanofi) led to rapid and durable platelet responses, reduced bleeding and need for rescue therapy, and improved health-related quality of life …
Rilzabrutinib Shines in Phase 3 Trial of Tough-to-Treat ITP Read More »
SAN DIEGO — Recipients of allogeneic hematopoietic cell transplantation (allo-HCT) for blood disorders who maintain diets high in fiber show significant improvements in overall survival and a reduced risk of developing the potentially life-threatening complication of acute graft-versus-host disease (aGVHD), new research shows. Importantly, the findings suggest standard recommendations for patients of a low-fiber diet …
High-Fiber Diet Linked to Improved Stem Cell Transplant, GvHD Outcomes Read More »
SAN DIEGO — Patients with multiple myeloma who receive intravenous immunoglobulin (IVIG) prophylaxis during treatment with teclistamab have fewer infections and better overall survival compared with those who do not receive IVIG prophylaxis, according to new findings presented here at the American Society of Hematology (ASH) 2024 Annual Meeting. Among 225 consecutive patients who received …
IVIG Prophylaxis in Myeloma Cuts Infections, Ups Survival Read More »
SAN DIEGO — The addition of the bispecific T-cell engager blinatumomab (Blincyto) to chemotherapy greatly boosted 3-year disease-free survival (DFS) in younger pediatric patients with newly diagnosed, standard-risk B-cell acute lymphoblastic leukemia (B-ALL), in a phase 3 randomized trial. Among pediatric patients with B-ALL followed for a mean of 2.5 years (1.6-3.2 years), 718 patients …
With Chemo, Blinatumomab Boosts DFS in Pediatric B-ALL Read More »